Celldex Therapeutics, Inc.

CLDX·NASDAQ·$30.85Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/25/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report09/22/26 8-KCurrent report08/06/26 8-KCurrent report07/15/26 8-KCurrent report06/26/26 8-KCurrent report05/07/26

Prospectuses and Registrations

S-8Registration of securities for employees06/26/26 424B5Prospectus supplement04/02/26 424B5Prospectus supplement04/01/26 S-8Registration of securities for employees06/06/25 S-8Registration of securities for employees06/14/24

Proxies

DEF 14ADefinitive proxy04/29/26 DEF 14ADefinitive proxy04/21/25 DEF 14ADefinitive proxy04/25/24 DEF 14ADefinitive proxy04/25/23 DEF 14ADefinitive proxy04/26/22

Ownership

SC 13G/ABeneficial ownership (amended)10/07/26 SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction06/29/26 Form 4Insider transaction06/29/26

Other

ARSAnnual report to shareholders04/29/26 ARSAnnual report to shareholders04/21/25 ARSAnnual report to shareholders04/25/24 ARSAnnual report to shareholders04/25/23 CORRESPCorrespondence with the SEC06/12/20